US · Healthcare

Jyong Biotech Ltd. Ordinary Shares (MENS)

Biotechnology

Jyong Biotech Ltd. Ordinary Shares (MENS) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for MENS

P/E ratio

25.00

Jyong Biotech Ltd. Ordinary Shares (MENS) — FAQ

What is MENS's P/E ratio?

The price-to-earnings (P/E) ratio for Jyong Biotech Ltd. Ordinary Shares (MENS) is 25.00 (data as of 2026-05-23).

Does Jyong Biotech Ltd. Ordinary Shares pay a dividend?

Dividend yield is not available in the current snapshot for Jyong Biotech Ltd. Ordinary Shares (MENS). Check the MyAverix Finance app for the latest dividend data.

What sector is Jyong Biotech Ltd. Ordinary Shares in?

Jyong Biotech Ltd. Ordinary Shares (MENS) is classified in the Healthcare sector (Biotechnology industry).

What exchange is MENS listed on?

MENS is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)